Addressing Asymptomatic Plasmodium Reservoirs to Accelerate Malaria Elimination and Eradication in Rwanda.
Malaria,Falciparum
About this trial
This is an interventional treatment trial for Malaria,Falciparum
Eligibility Criteria
Inclusion Criteria: Confirmed as asymptomatic reservoir of Plasmodium in the community or after completing standard malaria treatment. Leave for at least one month in Rwanda for non-national Be between 18 and 65 years of age, and in good general health. Not taking any other malaria drug for prevention or treatment. Children 5 years and above will be recruited as index cases for household cluster survey. Exclusion Criteria: Have known hypersensitivity to any ingredients of the test treatment. Have participated in any other malaria drug trial or device less than 14 days before. History or presence of clinically significant medical, psychiatric, or emotional condition that would compromise the safety of the subject or adherence to the interventional requirements. Be pregnant
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
No Intervention
Artemisia Afra
Artemisia Annua
No treatment
artemisia afra 10g/ day for 14 days
artemisia annua 10g/ day for 14 days